Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing

ACS Chemical Biology

Volumn 6, Issue 6, 2011, Pages 582-589

  Fan, Liying ^a   Lagisetti, Chandraiah ^a   Edwards, Carol C ^a   Webb, Thomas R ^a   Potter, Philip M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FR 901464; NATURAL PRODUCT; PLADIENOLIDE; PROTEIN MDM2; SPLICEOSTATIN A; SUDEMYCIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; DRUG EXPOSURE; ENANTIOSELECTIVITY; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; MOUSE; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; SPLICEOSOME; TUMOR CELL LINE; TUMOR XENOGRAFT;

ALTERNATIVE SPLICING; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; HUMANS; MICE; MICE, SCID; MOLECULAR CONFORMATION; MOLECULAR WEIGHT; PROTO-ONCOGENE PROTEINS C-MDM2; PYRANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPIRO COMPOUNDS; STEREOISOMERISM; TRANSCRIPTION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 79961049732     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb100356k     Document Type: Conference Paper

References (21)

1. Kaida, D., Motoyoshi, H., Tashiro, E., Nojima, T., Hagiwara, M., Ishigami, K., Watanabe, H., Kitahara, T., Yoshida, T., Nakajima, H., Tani, T., Horinouchi, S., and Yoshida, M. (2007) Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat. Chem. Biol. 3, 576-583. (Pubitemid 47294395)
2. Kotake, Y., Sagane, K., Owa, T., Mimori-Kiyosue, Y., Shimizu, H., Uesugi, M., Ishihama, Y., Iwata, M., and Mizui, Y. (2007) Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat. Chem. Biol. 3, 570-575. (Pubitemid 47294394)
3. Lardelli, R. M., Thompson, J. X., Yates, J. R., and Stevens, S. W. 2010 Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing. RNA 16, 516-528.
4. Albert, B. J., Sivaramakrishnan, A., Naka, T., Czaicki, N. L., and Koide, K. (2007) Total syntheses, fragmentation studies, and antitumor/ antiproliferative activities of FR901464 and its low picomolar analogue. J. Am. Chem. Soc. 129, 2648-2659. (Pubitemid 46364073)
5. Mizui, Y., Sakai, T., Iwata, M., Uenaka, T., Okamoto, K., Shimizu, H., Yamori, T., Yoshimatsu, K., and Asada, M. (2004) Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities. J. Antibiot. 57, 188-196. (Pubitemid 38489677)
6. Nakajima, H., Hori, Y., Terano, H., Okuhara, M., Manda, T., Matsumoto, S., and Shimomura, K. (1996) New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J. Antibiot. 49, 1204-1211.
7. Lagisetti, C., Pourpak, A., Goronga, T., Jiang, Q., Cui, X., Hyle, J., Lahti, J. M., Morris, S. W., and Webb, T. R. (2009) Synthetic mRNA splicing modulator compounds with in vivo antitumor activity. J. Med. Chem. 52, 6979-6990.
8. Lagisetti, C., Pourpak, A., Jiang, Q., Cui, X., Goronga, T., Morris, S. W., and Webb, T. R. (2008) Antitumor compounds based on a natural product consensus pharmacophore. J. Med. Chem. 51, 6220-6224.
9. Albert, B. J., McPherson, P. A., O'Brien, K., Czaicki, N. L., Destefino, V., Osman, S., Li, M., Day, B. W., Grabowski, P. J., Moore, M. J., Vogt, A., and Koide, K. (2009) Meayamycin inhibits premessenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells. Mol. Cancer Ther. 8, 2308-2318.
10. Ward, A. J., and Cooper, T. A. (2010) The pathobiology of splicing. J. Pathol. 220, 152-163.
11. Bartel, F., Taylor, A. C., Taubert, H., and Harris, L. C. (2001) Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines. Oncol. Res. 12, 451-457. (Pubitemid 33791805)
12. Taylor, A. C., Shu, L., Danks, M. K., Poquette, C. A., Shetty, S., Thayer, M. J., Houghton, P. J., and Harris, L. C. (2000) P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med. Pediatr. Oncol. 35, 96-103.
13. Logette, E., Wotawa, A., Solier, S., Desoche, L., Solary, E., and Corcos, L. (2003) The human caspase-2 gene: alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression. Oncogene 22, 935-946. (Pubitemid 36255829)
14. Iwanaga, N., Kamachi, M., Aratake, K., Izumi, Y., Ida, H., Tanaka, F., Tamai, M., Arima, K., Nakamura, H., Origuchi, T., Kawakami, A., and Eguchi, K. (2005) Regulation of alternative splicing of caspase-2 through an intracellular signaling pathway in response to proapoptotic stimuli. J. Lab. Clin. Med. 145, 105-110. (Pubitemid 40298737)
15. Fushimi, K., Ray, P., Kar, A., Wang, L., Sutherland, L. C., and Wu, J. Y. (2008) Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc. Natl. Acad. Sci. U. S.A. 105, 15708-15713.
16. Droin, N., Rebe, C., Bichat, F., Hammann, A., Bertrand, R., and Solary, E. (2001) Modulation of apoptosis by procaspase-2 short isoform: selective inhibition of chromatin condensation, apoptotic body formation and phosphatidylserine externalization. Oncogene 20, 260-269. (Pubitemid 32150271)
17. Sumanasekera, C.,Watt, D. S., and Stamm, S. (2008) Substances that can change alternative splice-site selection. Biochem. Soc. Trans. 36, 483-490. (Pubitemid 351839360)
18. Forsyth, N. R., Evans, A. P., Shay, J. W., and Wright, W. E. 2003 Developmental differences in the immortalization of lung fibroblasts by telomerase. Aging Cell 2, 235-243.
19. Singh, R. K., Tapia-Santos, A., Bebee, T. W., and Chandler, D. S. 2009 Conserved sequences in the final intron of MDM2 are essential for the regulation of alternative splicing of MDM2 in response to stress. Exp. Cell Res. 315, 3419-3432.
20. Nociari, M. M., Shalev, A., Benias, P., and Russo, C. (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cellmediated cytotoxicity. J. Immunol. Methods 213, 157-167. (Pubitemid 28332808)
21. Houghton, P. J., Cheshire, P. J., Hallman, J. D., 2nd, Lutz, L., Friedman, H. S., Danks, M. K., and Houghton, J. A. (1995) Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother. Pharmacol. 36, 393-403.